Strategies to select the best pharmacophore model: a case study in pyrazoloquinazoline class of PLK-1 inhibitors
Crossref DOI link: https://doi.org/10.1007/s00044-017-2057-9
Published Online: 2017-09-12
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Joshi, Akshada J.
Bhojwani, Heena R.
Joshi, Urmila J.
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology (DBT (BT/PR14373/MED/30/530/2010))
License valid from 2017-09-12